latest updates in the treatment of lr-mds: commands and imerge trials
Published 11 months ago • 199 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
1:25
the recent approval of imetelstat in lr-mds based on results of the imerge trial
-
1:44
imerge update: continuous transfusion independence & disease modification with imetelstat in lr-mds
-
2:51
analysis of the imerge trial: the disease-modifying potential of imetelstat in lr-mds
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
16:42
management of treatment-naïve lr-mds
-
42:46
cde series 26: updates in advanced hematology
-
2:35
will mrd change how we think about success in mm treatment?
-
1:45
updates on the treatment of mds
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
2:17
insights into the real-world efficacy of luspatercept in patients with lr-mds
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
7:05
state-of-the-art treatment regimens for lr-mds
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
1:34
personalizing treatment of transfusion-dependent anemia in lr-mds
-
2:43
novel therapies in the future of mds treatment
-
1:26
updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent
-
1:02
update on treatments for high- and low-risk mds
-
3:47
current and emerging treatment options for lr-mds-associated anemia following esa failure
-
1:17
the curative potential of allosct in the treatment of hr-mds